Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Abstract

BACKGROUND Conventional treatment of eosinophilic granulomatosis with polyangiitis (EGPA) (Churg-Strauss) with glucocorticoids, with or without additional immunosuppressive drugs, is limited by partial efficacy, frequent toxicity and a high relapse rate. Rituximab is a licensed treatment for granulomatosis with polyangiitis and microscopic polyangiitis and… (More)
DOI: 10.1136/annrheumdis-2014-206095

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics